Terms: = Bone cancer AND ER, estrogen receptor AND Treatment
924 results:
1. High incidence of imperforate vagina in ADGRA3-deficient mice.
Kvam JM; Nybo ML; Torz L; Sustarsic RK; Jensen KHR; Nielsen JE; Frederiksen H; Gadgaard S; Spiess K; Poulsen SS; Thomsen JS; Cowin P; Blomberg Jensen M; Kurita T; Rosenkilde MM
BMC Biol; 2024 Apr; 22(1):77. PubMed ID: 38589878
[TBL] [Abstract] [Full Text] [Related]
2. Can 18F-FES PET Improve the Evaluation of 18F-FDG PET in Patients With Metastatic Invasive Lobular Carcinoma?
Liu C; Ma G; Xu X; Song S; Yang Z
Clin Nucl Med; 2024 Apr; 49(4):301-307. PubMed ID: 38427956
[TBL] [Abstract] [Full Text] [Related]
3. The Effects of Fucoidan Derived from
Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
[TBL] [Abstract] [Full Text] [Related]
4. Women's Health Update: Growing Role of PET for Patients with Breast cancer.
Ulaner GA; Vaz SC
Semin Nucl Med; 2024 Mar; 54(2):247-255. PubMed ID: 38365547
[TBL] [Abstract] [Full Text] [Related]
5. Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Palmieri C; Linden H; Birrell SN; Wheelwright S; Lim E; Schwartzberg LS; Dwyer AR; Hickey TE; Rugo HS; Cobb P; O'Shaughnessy JA; Johnston S; Brufsky A; Tilley WD; Overmoyer B
Lancet Oncol; 2024 Mar; 25(3):317-325. PubMed ID: 38342115
[TBL] [Abstract] [Full Text] [Related]
6. Novel Targeted Therapies for Rheumatoid Arthritis Based on Intracellular Signalling and Immunometabolic Changes: A Narrative Review.
Rahmati M; Kwesiga MP; Lou J; Tan AL; McDermott MF
Front Biosci (Landmark Ed); 2024 Jan; 29(1):42. PubMed ID: 38287839
[TBL] [Abstract] [Full Text] [Related]
7. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract] [Full Text] [Related]
8. Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population-based study.
Zhou X; Liu M; Zheng Z; Cao X; Lin Y; Xu Y; Li Y; Wang HC; Sun Q
Cancer; 2024 Apr; 130(S8):1464-1475. PubMed ID: 38198445
[TBL] [Abstract] [Full Text] [Related]
9. Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence.
Kazemzadeh F; Snoek JAA; Voorham QJ; van Oijen MGH; Hugen N; Nagtegaal ID
Breast Cancer; 2024 Mar; 31(2):263-271. PubMed ID: 38133738
[TBL] [Abstract] [Full Text] [Related]
10. Long-Term Follow-Up of Tamoxifen treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.
Gideonsson I; Israelsson P; Strandberg SN; Ottander U
Curr Oncol; 2023 Nov; 30(12):10260-10271. PubMed ID: 38132381
[TBL] [Abstract] [Full Text] [Related]
11. A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent cancer Cells.
Calvo V; Zheng W; Adam-Artigues A; Staschke KA; Huang X; Cheung JF; Nobre AR; Fujisawa S; Liu D; Fumagalli M; Surguladze D; Stokes ME; Nowacek A; Mulvihill M; Farias EF; Aguirre-Ghiso JA
Clin Cancer Res; 2023 Dec; 29(24):5155-5172. PubMed ID: 37982738
[TBL] [Abstract] [Full Text] [Related]
12. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast cancer with Focus on Triple-negative Breast cancer.
Naeimzadeh Y; Heidari Z; Razban V; Khajeh S
Curr Mol Pharmacol; 2024; 17(1):e18761429263841. PubMed ID: 37916633
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
14. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
Zhong X; Lin Y; Zhang W; Bi Q
Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
[TBL] [Abstract] [Full Text] [Related]
15. Design, synthesis, and in-silico study of novel triarylethylene analogs with dual anti-estrogenic and serotonergic activity.
Mostafa T; Albeir M; Wober J; Abadi A; Salama I; Ahmed NS
Drug Dev Res; 2024 Feb; 85(1):e22127. PubMed ID: 37877739
[TBL] [Abstract] [Full Text] [Related]
16. Phase II study of apatinib plus exemestane in estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer.
Tan A; Nong L; Wang H; Jia Y; Zhong W; Qin F; Wang H; Tang J; Liu Y; Lu Y
Cancer Biol Ther; 2023 Dec; 24(1):2265055. PubMed ID: 37831547
[TBL] [Abstract] [Full Text] [Related]
17. Predicting Patterns of Distant Metastasis in Breast cancer Patients following Local Regional Therapy Using Machine Learning.
Shiner A; Kiss A; Saednia K; Jerzak KJ; Gandhi S; Lu FI; Emmenegger U; Fleshner L; Lagree A; Alera MA; Bielecki M; Law E; Law B; Kam D; Klein J; Pinard CJ; Shenfield A; Sadeghi-Naini A; Tran WT
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761908
[TBL] [Abstract] [Full Text] [Related]
18. GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.
Gallo Cantafio ME; Torcasio R; Scionti F; Mesuraca M; Ronchetti D; Pistoni M; Bellizzi D; Passarino G; Morelli E; Neri A; Viglietto G; Amodio N
Cells; 2023 Sep; 12(18):. PubMed ID: 37759449
[TBL] [Abstract] [Full Text] [Related]
19. Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma.
Cimmino A; Fasciglione GF; Gioia M; Marini S; Ciaccio C
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686148
[TBL] [Abstract] [Full Text] [Related]
20. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract] [Full Text] [Related]
[Next]